United Therapeutics Corp
XBER:UTH
United Therapeutics Corp
XBER:UTH
Price:
427.4
EUR
Market Closed
Market Cap:
€12B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
U
|
United Therapeutics Corp
XBER:UTH
|
US |
|
B
|
Becton Dickinson and Co
XBER:BOX
|
US |
|
C
|
CureVac NV
XBER:5CV
|
DE |
Shareholder Yield
Current shareholder yield for 
UTH is
.
Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest
Peers Comparison
Shareholder Yield
Shareholder Yield
Price Appreciation
UTH Price
United Therapeutics Corp
United Therapeutics Corp
Annual Price Range
427.4
52w Low
240.3
52w High
439.1
Price Metrics
| Average Annual Return | 25.68% |
| Standard Deviation of Annual Returns | 38.31% |
| Max Drawdown | -13% |
Shares Statistics
| Market Capitalization | 24B EUR |
| Shares Outstanding | 28 027 732 |
| Percentage of Shares Shorted |
N/A
|
UTH Return Decomposition
Main factors of price return
Main factors of price return
Stock Splits
UTH's latest stock split occurred on Sep 23, 2009
The company executed a 2-for-1 stock split, meaning that for every share held, investors received 2 new shares.
The adjusted shares began trading on Sep 23, 2009. This was the only stock split in UTH's history.
Pre-Split Price
N/A
Post-Split Price
34.85
Before
After
